10-K/A XBRL

FORM 10-KA AMENDED ANNUAL REPORT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: September 14, 2017
Period of Report: December 31, 2016
Accession Number: 0001078782-17-001262

View Document ↗ View on SEC.gov ↗